ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody–drug conjugate (ADC) targeting low HER2-expressing solid cancers
Zammarchi, F, Chivers, S, Williams, D.G, Adams, L, Mellinas-Gomez, M, Tyrer, P, Corbett, S, D'Hooge, F, Dissanayake, S, Sims, S, Havenith, K, Howard, P.W, Hartley, J.A, Van Berkel, P.H
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
FIRST CLINICAL RESULTS OF ADCT‐402, A NOVEL PYRROLOBENZODIAZEPINE‐BASED ANTIBODY DRUG CONJUGATE (ADC), IN RELAPSED/REFRACTORY B‐CELL LINEAGE NHL
Kahl, B., Hamadani, M., Caimi, P.F., Reid, E.G., Havenith, K., He, S., Feingold, J.M., O'Connor, O.A.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
INTERIM DATA FROM THE FIRST CLINICAL STUDY OF ADCT‐301, A NOVEL PYRROLOBENZODIAZAPINE‐BASED ANTIBODY DRUG CONJUGATE, IN RELAPSED/REFRACTORY HODGKIN/NON‐HODGKIN LYMPHOMA
Horwitz, S.M., Fanale, M.A., Spira, A.I., Havenith, K., He, S., Feingold, J.M., Hamadani, M.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article
1030P First-in-human study of camidanlumab tesirine (ADCT-301, Cami), an anti-CD25 targeted therapy in patients (pts) with advanced solid tumours: Pharmacokinetics (PK) and biomarker evaluation
Puzanov, I., Havenith, K., Boni, J., Cruz, H.G., Anderson, K., Kopotsha, T., Le Bruchec, Y., Bendell, J.C., Kummar, S., Papadopoulos, K.P., LoRusso, P., Wuerthner, J.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
62 - ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody–drug conjugate (ADC) targeting low HER2-expressing solid cancers
Zammarchi, F., Chivers, S., Williams, D.G., Adams, L., Mellinas-Gomez, M., Tyrer, P., Corbett, S., D'Hooge, F., Dissanayake, S., Sims, S., Havenith, K., Howard, P.W., Hartley, J.A., Van Berkel, P.H.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON‐HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS
Depaus, J, Wagner‐Johnston, N, Zinzani, P. L, Phillips, T. J, Maly, J, Ferrari, S, Bachy, E, Bryan, L. J, Delwail, V, Janakiram, M, de Guibert, S, Tani, M, Dai, V, Havenith, K, Boni, J, He, X, Ervin‐Haynes, A, Carlo‐Stella, C
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
A subset of splenic macrophages process and present native antigen to naive antigen-specific CD4 super(+) T-cells from mice transgenic for an alpha beta T-cell receptor
Askew, D, Gatewood, J, Olivas, E, Havenith, K, Walker, W S
Published in Cellular immunology (01.01.1995)
Get full text
Published in Cellular immunology (01.01.1995)
Journal Article